Press Releases

Coincheck Group N.V. (NASDAQ:CNCK) ("Coincheck Group" or the "Company"), a Dutch public limited liability company that provides digital asset trade execution, custody, staking and asset management services, and DFNS, a leading wallet infrastructure for institutional finance, today announced the signing of a strategic partnership focused on digital asset wallet technology and custody services in Japan. DFNS and Coincheck Group plan to collaborate on the deployment of DFNS’s technology to support Coincheck Group’s Japanese subsidiary, Coincheck, Inc., the Tokyo-based retail crypto asset exchange provider. This should enable Coincheck to support the development of secure, institutional-grade

TOKYO and CAMBRIDGE, Mass., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. and Biogen Inc. (NASDAQ:BIIB), announced today that Canada’s Drug Agency (CDA-AMC) has issued a final recommendation supporting public reimbursement of LEQEMBI® (lecanemab) for eligible patients in Canada living with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease (early AD). The final recommendation follows a reconsideration by CDA-AMC and is an important step toward access to LEQEMBI. Next steps include negotiations through the pan-Canadian Pharmaceutical Alliance (pCPA), followed by individual reimbursement decisions by public drug plans in Canada’s provinces and territories. More

At a glance Network readiness: Verizon has prepared its network with backup generators, satellite assets, and pre-staged equipment designed for reliability during severe weather.Customer resources: Verizon offers digital preparedness steps to help the community stay connected and secure ahead of the storm.Satellite messaging: Verizon customers can maintain essential communications via satellite, allowing compatible phones to send text messages or connect with emergency services. HOUSTON, Aug. 31, 2026 (GLOBE NEWSWIRE) -- As potential Tropical Storm Edouard forms in the Gulf, Verizon has readied its network and remains on standby to ensure connectivity. Verizon Prepares Network along Gul

Shares of Combined Company, to Be Renamed XTEND AI Robotics, Expected to Begin Trading on the NYSE Under the Ticker Symbol "XTND" on September 4, 2026 TAMPA, Fla., Aug. 31, 2026 (GLOBE NEWSWIRE) -- JFB Construction Holdings (NASDAQ:JFB) and XTEND, a leader in software systems and artificial intelligence-powered robotics, announced today that the previously announced business combination between JFB and XTEND Reality Expansion Ltd. remains on track to close on September 3, 2026. Upon closing, the combined company will be renamed XTEND AI Robotics, Inc., and its common stock is expected to begin trading on the New York Stock Exchange ("NYSE") under the ticker symbol "XTND" on September 4, 2

DALLAS, Aug. 31, 2026 /PRNewswire/ -- Solidion Technology Inc. ("Solidion" or the "Company") (NASDAQ:STI), an advanced battery technology solutions provider, today announced the appointment of Kimi L. Ellen, Mark N. Schwartz, and Dante W. Robinson as independent directors to its Board of Directors, effective August 31. Each of the new directors has been determined by the Board to be independent under the applicable listing standards of The Nasdaq Stock Market and applicable rules of the U.S. Securities and Exchange Commission. The appointments strengthen the financial, audit, and governance expertise of Solidion's Board and its

Delek US Holdings, Inc. (NYSE:DK) welcomes President Trump and the U.S. Environmental Protection Agency's decision granting Small Refinery Exemptions ("SREs") for the 2025 compliance year. This decision helps protect American jobs and supports continued investment in the communities served by small refineries."We thank President Trump and Administrator Zeldin for recognizing the important role of SREs in supporting American workers and the communities we serve in Arkansas, Texas and Louisiana," said Avigal Soreq, President and Chief Executive Officer of Delek US Holdings. "This decision allows us to put more capital to work in our refineries, sustaining jobs, while strengthening U.S. energy

Saba Capital Income & Opportunities Fund II (NYSE:SABA) (the "Fund"), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the "Investment Company Act"). IMPORTANT INFORMATION REGARDING MONTHLY DISTRIBUTION Distribution Notice. Pursuant to Section 19(a) of the Investment Company Act, the Fund is providing its shareholders with an estimate of the source of the Fund's monthly distribution as required by current securities laws. The Fund’s estimated sources of the distribution to be

Wilmington, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) will host a live Innovation Day webcast for analysts and investors from Wilmington, Delaware on September 17, 2026. The event will provide an updated view of Ashland’s Technology Platforms, including their commercial progress and scalability.  Registration is required and can be accessed from the following link: innovationday26.ashland.com Participants will hear from Ashland executives and senior technology leaders as they provide an in-depth review of the latest innovations and expanding commercial opportunities. The presentations will detail how these advancements are poised to impact key markets and drive organ

Saba Capital Income & Opportunities Fund (NYSE:BRW) (the "Fund"), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the "Investment Company Act"). IMPORTANT INFORMATION REGARDING MONTHLY DISTRIBUTION Distribution Notice. Pursuant to Section 19(a) of the Investment Company Act, the Fund is providing its shareholders with an estimate of the source of the Fund's monthly distribution as required by current securities laws. The Fund’s estimated sources of the distribution to be paid

David Gill appointed Chair of the Telix Board, effective immediately.Mr. Gill joined Telix as a Non-Executive Director in May 2026, with the intention that he would become Chair.Dr. Mark Nelson will continue to serve on the Board as a Non-Executive Director, having served as interim Chair. MELBOURNE, Australia and INDIANAPOLIS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ:TLX, "Telix" or the "Company") today announces that David Gill has been appointed Chair of the Board, effective immediately. Mr. Gill joined Telix as a Non-Executive Director in May 2026 as part of the Company’s Board expansion and succession planning1, with the intention that he wo

BURLINGAME, Calif., Aug. 31, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (NASDAQ:ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that the Company will present data from the ENABLE Phase 1 clinical trial of ELVN-001 in an oral and a poster presentation at the Society of Hematologic Oncology (SOHO) Annual Meeting, taking place September 9-12, 2026, at the George R. Brown Convention Center in Houston, Texas. This is an encore presentation of data that were previously presented at the European Hematology Association (EHA) 2026 Congress.Details of the presentation are as follows

Karman Space & Defense (NYSE:KRMN) is scheduled to participate in the following September investor conferences: 2026 Jefferies Global Industrials Conference on September 10 in New York City Morgan Stanley 14th Annual Laguna Conference on September 16 in Dana Point, CA Karman management will host institutional investor meetings at the conferences. Institutional investors may contact Jefferies and Morgan Stanley to request one-on-one meetings with management. Webcasts of management fireside chats at the conferences will be accessible via the Investors section of the Company’s website at https://investors.karman-sd.com/. ABOUT KARMAN SPACE & DEFENSE Karman Space & Defense is a lea

Transaction with Progress Software is Expected to Close by the End of September 2026 Domo, Inc. (NASDAQ:DOMO) ("Domo" or the "Company") today announced that it expects to file its Quarterly Report on Form 10-Q for its second quarter ended July 31, 2026, on Thursday, September 3, 2026, after the market closes. Domo will report its quarterly financial results through the Form 10-Q and does not plan to issue a separate earnings release. Due to the pending transaction with Progress Software Corporation (NASDAQ:PRGS) ("Progress"), the company will not host a conference call or webcast to discuss the results. Once filed, the Form 10-Q will be available on Domo’s Investor Relations website a

Abstracts highlight epetraborole’s potential beneficial effects on hematological profile across clinical and nonclinical studies AN2 Therapeutics, Inc. (NASDAQ:ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today announced that four abstracts highlighting clinical and nonclinical data supporting the development of epetraborole, a novel boron-containing oral candidate for the treatment of polycythemia vera (PV), will be presented at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting, taking place September 9-12, 2026, at the George R. Brown Convention Cent

Marks Ares Real Estate’s Largest Closed-End Institutional Fundraise to Date Ares Management Corporation (NYSE:ARES) ("Ares"), a leading global alternative investment manager, announced today the final close of Japan Logistics Development Partners V LP ("JDP V" or the "Fund"), the latest vintage in its Japan-focused logistics real estate development fund series. Raising ¥612 billion (approximately US$4 billion1), including LP equity commitments and GP commitment, JDP V closed at its hard cap and is nearly 50% larger than its predecessor 2021-vintage JDP IV. The Fund attracted commitments from a diversified global investor base comprising pension funds, sovereign wealth funds, insurance c

WATERTOWN, Mass., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it will present data from multiple clinical programs, including an oral presentation of initial data from the RESTORE-PV trial of DISC-3405 in patients with polycythemia vera (PV), at the SOHO Annual Meeting, which will be held in Houston, Texas on September 9-12, 2026. "We are excited to share the first clinical data from our Phase 2 study of DISC-3405 in polycythemia vera at the upcoming SOHO conferenc

TAIPEI, Taiwan, Aug. 31, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited ("YD Bio" or the "Company") (NASDAQ:YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic innovations, today announced its financial results for the six months ended June 30, 2026. Management Commentary"The first half of 2026 marks a historic turning point for YD Bio, highlighted by our transition to bottom-line profitability and a remarkable 315% surge in top-line revenue," said Dr. Ethan Shen, Chairman and CEO of YD Bio. "This explosive growth is the direct result of our proactive commercial strategies, which successfully expanded our volume footprint with existing cu

Company to host a corporate update call Tuesday, September 1st at 8:00am ETSYDNEY, Aug. 31, 2026 /CNW/ -- Kazia Therapeutics Limited (NASDAQ:KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced the closing of its previously announced oversubscribed, tranched registered public offering (the "Offering") generating approximately $40 million in upfront gross proceeds. Both clinical milestone-linked warrant tranches were priced at premiums to the $15.50 offering price, with exercise prices of $17.825 per ADS, a 15% premium, tied to t

BOCA RATON, FL, Aug. 31, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (NASDAQ:DFDV) (the "Company"), the first U.S. public company with a treasury strategy built around accumulating and compounding Solana (SOL), today announced that it intends to conduct an initial public offering registered under the Securities Act of 1933, as amended, of up to $20 million of shares of its Variable Rate Series C Perpetual Preferred Stock (the "CHAD Stock"). The Company also expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the number of shares of CHAD Stock offered in the offering. The offering is subject to market and other conditions, and there can be no assuranc

MONETT, Mo., Aug. 31, 2026 /PRNewswire/ -- Jack Henry & Associates Inc.® (NASDAQ:JKHY) today issued the following statement on its response to a recent cybersecurity incident: "Jack Henry recently detected a cybersecurity incident within a limited portion of our internal, non-production corporate environment. No client-facing systems, operating systems, core platforms, or daily processing services were accessed or disrupted, and they all remain secure and fully operational. We did not experience any system outages.Protecting the financial institutions we serve and maintaining transparency are fundamental to everything we do at